Menu
Back to User profile » Dr Wenyu Ye
Papers published by Dr Wenyu Ye:
Real-World Treatment Patterns and Outcomes Among Patients with Episodic Migraine in China: Results from the Adelphi Migraine Disease Specific Programme™
Zhao H, Xiao Z, Zhang L, Ford J, Zhong S, Ye W, Li J, Tockhorn-Heidenreich A, Cotton S, Chen C
Journal of Pain Research 2023, 16:357-371
Published Date: 3 February 2023
Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study
Varnado OJ, Manjelievskaia J, Ye W, Perry A, Schuh K, Wenzel R
Patient Preference and Adherence 2022, 16:821-839
Published Date: 29 March 2022
Patient-Reported Outcomes for Migraine in the US and Europe: Burden Associated with Multiple Preventive Treatment Failures
Ford J, Nichols RM, Ye W, Tockhorn-Heidenreich A, Cotton S, Jackson J
ClinicoEconomics and Outcomes Research 2021, 13:647-660
Published Date: 14 July 2021
Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis
Yang YC, Du F, Ye WY, Chen Y, Li JH, Zhang J, Nicely H, Burge R
ClinicoEconomics and Outcomes Research 2015, 7:205-212
Published Date: 13 April 2015
Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS
Neuropsychiatric Disease and Treatment 2015, 11:983-990
Published Date: 7 April 2015
Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
Montgomery W, Kadziola Z, Ye W, Xue HB, Liu L, Treuer T
Neuropsychiatric Disease and Treatment 2015, 11:177-183
Published Date: 19 January 2015
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
Ye W, Montgomery W, Kadziola Z, Liu L, Xue H, Stensland MD, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:869-878
Published Date: 16 May 2014